Safety and Efficacy in Pediatric Patients with Relapsed/Refractory Classic Hodgkin Lymphoma Enrolled on an Intergroup Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin (E4412)

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Blood

Topics

Physics

Cancer Oncology

Medicine

Internal Medicine

Neurology

Show all topics

DOI

10.1182/blood-2024-201624